These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9268758)

  • 1. Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both.
    Bonifaz A; Martínez-Soto E; Carrasco-Gerard E; Peniche J
    Int J Dermatol; 1997 Jul; 36(7):542-7. PubMed ID: 9268758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK; Taborda PR; Sanzovo AD
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy.
    Kullavanijaya P; Rojanavanich V
    Int J Dermatol; 1995 Nov; 34(11):804-7. PubMed ID: 8543418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
    Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
    Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating chromoblastomycosis with systemic antifungals.
    Bonifaz A; Paredes-Solís V; Saúl A
    Expert Opin Pharmacother; 2004 Feb; 5(2):247-54. PubMed ID: 14996622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
    Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromoblastomycosis associated with Fonsecaea pedrosoi in a carpenter handling exotic woods.
    Menezes N; Varela P; Furtado A; Couceiro A; Calheiros I; Rosado L; Mota G; Baptista A
    Dermatol Online J; 2008 Feb; 14(2):9. PubMed ID: 18700112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal chromoblastomycosis.
    Barton K; Miller D; Pflugfelder SC
    Cornea; 1997 Mar; 16(2):235-9. PubMed ID: 9071540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide Morphologic Variability of Chromoblastomycosis in the Western Hemisphere.
    Mugleston BJ; Usatine RP; Rosen T
    Skinmed; 2016; 14(6):423-427. PubMed ID: 28031127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE.
    Queiroz-Telles F
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):46-50. PubMed ID: 26465369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Successful Treatment of Chromoblastomycosis Caused by
    Bao F; Wang Q; Yu C; Shang P; Sun L; Zhou G; Wu M; Zhang F
    Am J Trop Med Hyg; 2018 Jul; 99(1):124-126. PubMed ID: 29785921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis.
    Ungpakorn R; Reangchainam S
    Clin Exp Dermatol; 2006 Mar; 31(2):245-7. PubMed ID: 16487103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyphellophora laciniata: A new etiological agent of chromoblastomycosis.
    León-Lara X; Atoche C; Arenas R; Martínez-Hernández F; Martínez-Chavarría LC; Xicohtencatl-Cortes J; Vázquez-Aceituno VA; Hernández-Castro R
    J Mycol Med; 2022 Mar; 32(1):101204. PubMed ID: 34598111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromomycosis: report of a case with unusual topography].
    Muñoz Estrada VF; Valenzuela Paz GA; Rochín Tolosa M
    Rev Iberoam Micol; 2011; 28(1):50-2. PubMed ID: 21167297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.